BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess differences in changes in plasma lipids between
patients on saquinavir/ritonavir or atazanavir/ritonavir in combination with tenofovir
disoproxil fumarate and emtricitabine as a first-line regimen in patients previously naive
for antiretroviral therapy. This study is an extension from the SSAR 2004/0002 which
randomised patients over the same treatment arms.